Truist Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Buy
7,701
+1,596
+26% +$543K ﹤0.01% 1179
2025
Q4
$2.43M Sell
6,105
-361
-6% -$160K ﹤0.01% 1186
2025
Q3
$2.95M Buy
6,466
+2,459
+61% +$1M ﹤0.01% 1141
2025
Q2
$1.31M Buy
4,007
+383
+11% +$106K ﹤0.01% 1472
2025
Q1
$979K Sell
3,624
-774
-18% -$199K ﹤0.01% 1531
2024
Q4
$1.03M Buy
4,398
+2,539
+137% +$668K ﹤0.01% 1535
2024
Q3
$511K Buy
1,859
+131
+8% +$34.1K ﹤0.01% 1848
2024
Q2
$420K Sell
1,728
-623
-26% -$98.4K ﹤0.01% 2079
2024
Q1
$351K Sell
2,351
-127
-5% -$21.2K ﹤0.01% 2209
2023
Q4
$474K Buy
+2,478
New +$422K ﹤0.01% 2016
2023
Q2
Sell
-1,328
Closed -$266K 2563
2023
Q1
$266K Sell
1,328
-140
-10% -$29.4K ﹤0.01% 2287
2022
Q4
$349K Buy
+1,468
New +$313K ﹤0.01% 2181
2022
Q3
Sell
-5,000
Closed -$729K 2514
2022
Q2
$729K Sell
5,000
-1,924
-28% -$273K ﹤0.01% 1697
2022
Q1
$1.13M Sell
6,924
-671
-9% -$102K ﹤0.01% 1570
2021
Q4
$1.29M Buy
7,595
+992
+15% +$184K ﹤0.01% 1507
2021
Q3
$1.25M Buy
6,603
+40
+0.6% +$7.5K ﹤0.01% 1488
2021
Q2
$1.11M Buy
6,563
+838
+15% +$123K ﹤0.01% 1576
2021
Q1
$808K Buy
5,725
+3,972
+227% +$598K ﹤0.01% 1711
2020
Q4
$228K Buy
1,753
+374
+27% +$49.9K ﹤0.01% 2321
2020
Q3
$201K Sell
1,379
-390
-22% -$55.4K ﹤0.01% 2259
2020
Q2
$262K Sell
1,769
-168
-9% -$22.6K ﹤0.01% 2040
2020
Q1
$211K Sell
1,937
-201
-9% -$23.2K ﹤0.01% 2096
2019
Q4
$245K Buy
+2,138
New +$213K ﹤0.01% 2264

Other funds holding ALNY